HOLLY HAEBERLEIN: Open Payments
NPI 1932537800 · BANGOR, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 45 payments from 10 companies in 2025. Trend: 2023 $2,137 · 2024 $555 · 2025 $494
Food & beverage: $409Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $105 |
| Janssen Biotech, Inc. | 2 | $57 |
| Organon LLC | 5 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| UCB, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: SKYRIZI, TREMFYA, VTAMA, Rhapsido, Bimzelx, RINVOQ, DUPIXENT, ILUMYA.
Industry payments across ME — which companies pay providers there.
